Teacher Retirement System of Texas Sells 2,037 Shares of STERIS plc $STE

Teacher Retirement System of Texas cut its holdings in STERIS plc (NYSE:STE) by 13.6% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 12,887 shares of the medical equipment provider’s stock after selling 2,037 shares during the period. Teacher Retirement System of Texas’ holdings in STERIS were worth $3,189,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of STE. Jones Financial Companies Lllp boosted its holdings in STERIS by 46.1% during the 1st quarter. Jones Financial Companies Lllp now owns 1,106 shares of the medical equipment provider’s stock valued at $251,000 after acquiring an additional 349 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of STERIS by 32.3% during the first quarter. Goldman Sachs Group Inc. now owns 242,732 shares of the medical equipment provider’s stock valued at $55,015,000 after purchasing an additional 59,264 shares during the period. Empowered Funds LLC grew its holdings in shares of STERIS by 16.1% in the first quarter. Empowered Funds LLC now owns 2,303 shares of the medical equipment provider’s stock worth $522,000 after purchasing an additional 319 shares during the last quarter. Woodline Partners LP increased its stake in shares of STERIS by 40.0% in the first quarter. Woodline Partners LP now owns 8,300 shares of the medical equipment provider’s stock worth $1,881,000 after buying an additional 2,372 shares during the period. Finally, Jane Street Group LLC raised its holdings in STERIS by 38.9% during the 1st quarter. Jane Street Group LLC now owns 20,716 shares of the medical equipment provider’s stock valued at $4,695,000 after buying an additional 5,803 shares during the last quarter. 94.69% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other STERIS news, VP Julia Madsen sold 5,008 shares of the stock in a transaction on Friday, November 21st. The stock was sold at an average price of $262.00, for a total value of $1,312,096.00. Following the completion of the transaction, the vice president owned 10,710 shares in the company, valued at approximately $2,806,020. This represents a 31.86% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP John Adam Zangerle sold 15,000 shares of the business’s stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $265.14, for a total transaction of $3,977,100.00. Following the sale, the vice president owned 33,669 shares in the company, valued at approximately $8,926,998.66. This trade represents a 30.82% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 25,044 shares of company stock worth $6,586,218. Company insiders own 1.07% of the company’s stock.

STERIS Stock Down 0.9%

Shares of NYSE STE opened at $260.70 on Thursday. The firm has a fifty day simple moving average of $259.21 and a two-hundred day simple moving average of $248.25. STERIS plc has a 12 month low of $204.90 and a 12 month high of $269.44. The company has a current ratio of 2.37, a quick ratio of 1.63 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $25.59 billion, a PE ratio of 37.46 and a beta of 1.03.

STERIS (NYSE:STE) last announced its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.38 by $0.09. STERIS had a net margin of 12.07% and a return on equity of 14.43%. The company had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. During the same quarter in the previous year, the company earned $2.14 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. Equities analysts expect that STERIS plc will post 9.08 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “buy (b)” rating on shares of STERIS in a research report on Friday, January 9th. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $273.50.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.